View Older Stories View More Recent Stories

Apr 28, 2025 04:35PM Be Biopharma to Present at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
Apr 23, 2025 08:00AM Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025
Apr 17, 2025 11:00AM Scion Life Sciences Expands Team with Appointment of Three Venture Partners
Apr 15, 2025 07:00AM Remix Therapeutics Appoints Linda C. Bain to Board of Directors
Apr 7, 2025 09:00AM Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
Apr 7, 2025 02:00AM Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director
Mar 3, 2025 09:00AM Be Biopharma Announces Appointment of Susan Abu-Absi, Ph.D. as Chief Operating Officer
Feb 19, 2025 09:16AM NAYA Biosciences (NAYA) nominates new Board members
Feb 19, 2025 09:15AM NAYA Biosciences Announces Nomination of New Board Members
Feb 18, 2025 04:59PM Form SCHEDULE 13D Sionna Therapeutics, Filed by: Atlas Venture Fund XI, L.P.
Feb 18, 2025 03:30AM LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors
Feb 11, 2025 12:12PM Form 13F-NT Atlas Venture Associates For: Dec 31
Feb 11, 2025 12:08PM Form 13F-NT Atlas Venture Associates For: Dec 31
Feb 11, 2025 12:02PM Form 13F-NT Atlas Venture Fund VIII, For: Dec 31
Feb 11, 2025 11:59AM Form 13F-HR Atlas Venture Advisors, For: Dec 31
Feb 10, 2025 04:05PM Form 4 Sionna Therapeutics, For: Feb 10 Filed by: Atlas Venture Associates Opportunity II, LLC
Feb 6, 2025 09:13PM Form 3 Sionna Therapeutics, For: Feb 06 Filed by: Atlas Venture Fund XI, L.P.
Feb 6, 2025 04:59PM Form 13F-HR Atlas Venture Life Scien For: Dec 31
Feb 6, 2025 09:00AM Be Biopharma Announces Publication of Manuscript in the Molecular Therapy Journal Demonstrating In Vivo Engraftment and Tracking of Ex-vivo-Generated Plasma Cells in Non-Human Primates
Feb 5, 2025 04:06PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Feb 4, 2025 05:14PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Feb 3, 2025 04:28PM Form 144 Disc Medicine, Inc. Filed by: Atlas Venture Fund X, L.P.
Jan 29, 2025 08:00AM Kinaset Therapeutics Announces FDA Clearance of IND Application for frevecitinib (KN-002) in Asthma Treatment
Jan 15, 2025 09:00AM Be Bio Announces Closing of $92M Series C Financing and Completes Transition to a Multi-Program, Clinical Stage Company
Jan 9, 2025 08:15AM Lifordi Immunotherapeutics Appoints Matthew W. McClure, M.D., as Chief Medical Officer
Jan 9, 2025 07:00AM Arkuda Therapeutics Announces Option Exercise and Asset Purchase
Jan 8, 2025 09:00AM Actio Biosciences Expands Leadership Team with Appointment of Cayce Denton as Chief Financial Officer
Jan 7, 2025 09:00AM Be Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Dec 11, 2024 07:00AM Chroma Medicine and Nvelop Therapeutics Unite to Form nChroma Bio, Securing $75 Million to Accelerate Genetic Medicines
Dec 8, 2024 09:00PM Be Biopharma Unveils BeCoMe-9 Trial and Presents on Versatile B Cell Medicines Platform at ASH 2024
Dec 5, 2024 11:44AM Form D Atlas Venture Fund XIV,
Dec 5, 2024 07:00AM Atlas Venture Announces $450 Million Fund XIV
Dec 3, 2024 08:00AM K36 Therapeutics Announces Multiple Poster Presentations Highlighting the First Clinical Data for KTX-1001 and Other Developmental Compounds at the 66th American Society of Hematology (ASH) Annual Mee
Nov 18, 2024 08:00AM Rectify Pharma Presents Preclinical Data Supporting Development of Lead Candidate RTY-694 at The Liver Meeting® 2024
Nov 14, 2024 04:33PM Form SC 13G/A Dyne Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Nov 14, 2024 04:32PM Form SC 13G/A Kymera Therapeutics, Filed by: Atlas Venture Fund X, L.P.
Nov 14, 2024 04:31PM Form SC 13G/A Xilio Therapeutics, Inc. Filed by: Atlas Venture Fund XI, L.P.
Nov 14, 2024 04:30PM Form SC 13G/A Day One Biopharmaceutica Filed by: Atlas Venture Fund XI, L.P.
Nov 13, 2024 06:01AM Form 13F-HR Atlas Venture Life Scien For: Sep 30
Nov 12, 2024 08:00AM Rectify Pharma to Host Virtual R&D Event on RTY-694 for Primary Sclerosing Cholangitis and Other Hepatobiliary Diseases on November 21, 2024
Nov 12, 2024 07:00AM Trace Neuroscience Launches With $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases
Nov 5, 2024 06:27PM Form SC 13D/A Third Harmonic Bio, Inc. Filed by: Atlas Venture Fund XI, L.P.
Nov 5, 2024 04:15PM Form 4 Third Harmonic Bio, Inc. For: Nov 01 Filed by: Atlas Venture Fund XI, L.P.
Nov 5, 2024 09:05AM Be Biopharma Announces Upcoming Presentation at the 66th American Society of Hematology (ASH) Annual Meeting
Oct 31, 2024 09:45AM Form 13F-NT Atlas Venture Fund VIII, For: Sep 30
Oct 31, 2024 09:43AM Form 13F-NT Atlas Venture Associates For: Sep 30
Oct 31, 2024 09:43AM Form 13F-NT Atlas Venture Associates For: Sep 30
Oct 31, 2024 09:41AM Form 13F-HR Atlas Venture Advisors, For: Sep 30
Oct 28, 2024 06:09PM Form SC 13D/A Tectonic Therapeutic, Filed by: Atlas Venture Fund X, L.P.
Oct 22, 2024 12:00PM Be Bio Announces $82 Million Financing and Transition to Clinical Stage Company
View More Recent Stories View Older Stories